Abstract
Bording, A., K. Nymark, E. Smidt: Field trials with a new genetically engineered vaccine for protection against progressive atrophic rhinitis in pigs. Acta vet. scand. 1994, 35, 155-163.–Field trials were carried out testing a new genetically engineered vaccine against Progressive Atrophic Rhinitis. The vaccine contained a non-toxic recombinant derivative of the P. multocida toxin. The experimental vaccine was compared with a commercial vaccine in 4 farms and in 1 farm 2 different dose regimens were applied. A total of 825 sows were included. The primary efficacy variable was a comparison of post mortem evaluation of the degree of conchae atrophy in the 4585 pigs. The pigs were slaughtered at normal slaughter weight. The secondary efficacy variables were serological response and age at slaughter. In all farms the experimental vaccine provided significantly better protection of the progeny than the control vaccine. The serological response in sows was significantly higher in all farms than the response to the control vaccine. The serological response did not differ between farms.
Keywords: vaccination, Pasteurella multocida, toxin, derivative
Sammendrag
Der er blevet udført kliniske afprøvninger med en ny, gensplejset vaccine mod nysesyge (progressiv atrofisk rhinitis). Vaccinen indeholdt et ikke toksisk derivat af Pasteurella multocida toksinet. Derivatet var oprenset ved saltfældning før tilblanding til vaccinen. Den ekspenmentelle vaccine blev sammenlignet med en kommercielt tilgængelig toxoid vaccine mod atrofisk rhinitis i 4 besætninger. I en besætning blev den ekspenmentelle vaccine anvendt med to forskellige doseringer. I alt indgik der i undersøgelserne 826 søer og deres kuld fra 5 forskellige so- og slagtesvmebesætninger. Søerne ι begge forsøgsgrupper blev vaccineret to gange, 6-8 og 2-3 uger før faring. Vaccinernes effektivitet blev primært vurderet ved, at der efter grisenes slagtning ved normal slag-tevægt blev foretaget en sammenligning af graden af atrofi af næsehulens conchae hos 4.575 grise. Sekundært blev effekten vurderet ud fra søernes serologiske respons og grisenes alder ved slagtning. I alle besætningerne ydede den ekspenmentelle vaccine bedre beskyttelse af grisene end kontrolvaccinen. Det serologiske respons i søerne var signifikant højere i alle besætninger end responset mod kontrolvaccinen Det serologiske respons mod den ekspenmentelle vaccine var ens i de forskellige besætninger. I en besætning blev grisenes alder ved slagtning beregnet. Grise født af søer, der var vaccineret med den ekspenmentelle vaccine, nåede slagtevægten ca. 5 dage hurtigere end grise i den kontrolvaccinerede gruppe.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Acknowledgments
The authors wish to thank the veterinarians and the farmers and the slaughter houses making these field trials possible. The superb assistance provided by the technicians Anders Wamsler and Lis W. Johannsen is greatly appreciated.(Received July 19, 1993; accepted February 21, 1994).
References
- Barfod K, Pedersen KB. Influence of vaccination of sows with Bordetella-Pasteurella vaccines on occurrence of atrophic rhinitis among their offspring after experimental infection with Bordetella bronchiseptica and toxigenic Pasteurella multocida. Nord. Vet. Med. 1984;36:337–345. [PubMed] [Google Scholar]
- Barfod K, Sørensen V, Nielsen JP. Proc. 11th IPVS Congr. Lausanne. 1990. Methods of evaluation of the degree of atrophic rhinitis; p. 70. [Google Scholar]
- Nord. Vet. Med. 1971.
- Collins M B, Brim TA. Turbinate perimeter ratio as an indicator of conchal atrophy for diagnosis of atrophic rhinitis in pigs. Amer. J. vet. Res. 1989;50:421–424. [PubMed] [Google Scholar]
- de Jong MF, Oie HL, Tetenburg BJ. Proc. 6th IPVS Congr., Copenhagen. 1980. AR-pathogenicity-tests for Pasteurella multocida isolates; p. 211. [Google Scholar]
- Foged NT. Quantification and purification of Pasteurella multocida toxin by using monoclonal antibodies. Infect. Immun. 1988;56:1901–1906. doi: 10.1128/IAI.56.8.1901-1906.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Foged NT, Nielsen JP, Barfod K. Proc. 11th IPVS Congr. Lausanne. 1990. The use of ELIS A-determination for Pasteurella multocida toxin antibodies in control of progressive atrophic thinitis; p. 49. [Google Scholar]
- Foged NT, Nielsen JP, Pedersen KB. Differentiation of toxigenic from nontoxigenic isolates of Pasteurella multocida by enxyme-linked immunosorbent assay. J. clin. Microbiol. 1988;26:1419–1420. doi: 10.1128/JCM.26.7.1419-1420.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kobisch M, Pennings A. An evaluation in pigs of Nobi-Vac AR and an experimental atrophic rhinitis vaccine containing P multocida DNT-toxoid and B bronchiseptica. Vet. Rec. 1989;124:57–61. doi: 10.1136/vr.124.3.57. [DOI] [PubMed] [Google Scholar]
- Martin SW, Meek AH, Willeberg P. Veterinary Epidemiology, Principles and methods. Ames: Iowa State University Press; 1987. p. 343. [Google Scholar]
- Matthews DE, Farewell WT. Using and understanding medical statistics. 1988. p. 185. [Google Scholar]
- Nielsen JP: Pasteurella Nysesyge. Epidemiologi, diagnostik og eksperimentelle undersøgelser. Licentiat afhandling (Pasteurella atrophic rhinitis in pigs: Epidemiology, diagnostic and experimental investigations). Ph.D. Thesis. Nat.Vet. Lab. and Royal Vet. Agricult. Univ., Copenhagen.
- Nielsen JP, Foged NT, Sørensen V, Barfod K B, Petersen SK. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative. Can. J. vet. Res. 1991;55:128–138. [PMC free article] [PubMed] [Google Scholar]
- Pedersen KB N, Foged NT, Elling F, Nielsen NC, Willeberg P. Atrophic rhinitis in pigs: Proposal for a revised definition. Vet. Rec. 1988;122:190–191. doi: 10.1136/vr.122.8.190. [DOI] [PubMed] [Google Scholar]
- Pejsak Z, Hogg A, Wasinska B, Foreman K. Comparison of 6 different regimens for the control of atrophic rhinitis in swine. J. vet. Med. B. 1990;37:593–598. doi: 10.1111/j.1439-0450.1990.tb01102.x. [DOI] [PubMed] [Google Scholar]
- Petersen SK, Foged NT, Börding A, Nielsen JP, Riemann HK, Frandsen PL. Development of a recombinant vaccine against progressive atrophic rhinitis in pigs. Infect. Immun. 1991;59:1387–1393. doi: 10.1128/IAI.59.4.1387-1393.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SAS Institute Inc. SAS/STAT guide for personal computer. N.C.: SAS Institute, Cary; 1987. [Google Scholar]
- Schoss P. Neues über die Rhinitis atrophicans des Schweines. Wien. Tierärztl. Mschr. 1987;74:301–305. [Google Scholar]
- Sørensen V, Barfod K, Nielsen JP, Foged NT. Proc. 11th IPVS Congr. Lausanne. 1980. Effect of atrophy and serum antitoxin titer on the daily weight gain and feed conversion; p. 57. [Google Scholar]
- Voets MT. Proc. 10th IPVS Congr. Rio de Janeiro. 1988. Challenge experiments to test the protective effect of AR-vaccines; p. 42. [Google Scholar]
